Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less than 48 hours. Participants were randomized to p...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
«FIRMA «SILICEA» LLC
2005-12-01
|
| Schriftenreihe: | Российский кардиологический журнал |
| Schlagworte: | |
| Online-Zugang: | https://russjcardiol.elpub.ru/jour/article/view/2343 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|